Psychostimulants and movement disorders.

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Psychostimulants, including amphetamines and synthetic cathinones, are frequently abused substances.
• Recreational use of most psychostimulants is illegal, yet novel synthetic molecules bypass legal controls.
• Psychostimulant-related movement disorders are increasingly common in emergency settings.

Purpose of the Study:

• To review the clinical manifestations and underlying pathophysiological mechanisms of psychostimulant-induced movement disorders.
• To highlight the growing public health concern associated with psychostimulant abuse and associated movement disorders.

Main Methods:

• Literature review of psychostimulant effects on motor function.
• Analysis of clinical presentations and emergency room admission data.
• Examination of neurobiological pathways implicated in psychostimulant-induced movement disorders.

Main Results:

• Common symptoms include agitation, tremor, hyperkinetic and stereotypical movements, cognitive impairment, hyperthermia, and cardiovascular dysfunction.
• While acute movement disorders are frequent, chronic and permanent conditions are less common.
• Monoaminergic signaling, particularly involving dopamine, is a central mechanism, though other pathways are also involved.

Conclusions:

• Psychostimulant abuse poses a significant threat, evidenced by rising emergency room admissions for movement disorders.
• Understanding the complex neurobiological mechanisms is crucial for developing effective interventions.
• Further research into novel synthetic cathinones and their long-term neurological consequences is warranted.